Hysterectomy for benign disease: clinical practice guidelines from the ă French College of Obstetrics and Gynecology

Xavier Deffieux (xavier.deffieux@aphp.fr), Bertrand Rochambeau, Gautier Chêne, Tristan Gauthier, Samantha Huet, Gery Lamblin, Aubert Agostini, Maxime Marcelli and Francois Golfier
Additional contact information
Xavier Deffieux: Service de gynécologie-obstétrique, médecine de la reproduction [Béclère] - UP11 - Université Paris-Sud - Paris 11 - AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP) - AP-HP - Hôpital Antoine Béclère [Clamart] - AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP)
Gautier Chêne: ERTICa - Equipe de recherche sur les traitements individualisés des cancers - UdA - Université d'Auvergne - Clermont-Ferrand I
Tristan Gauthier: UP11 - Université Paris-Sud - Paris 11
Gery Lamblin: HFME - Hôpital Femme Mère Enfant [CHU - HCL] - HCL - Hospices Civils de Lyon

Post-Print from HAL

Abstract: Objective: The objective of the study was to draw up French College of ă Obstetrics and Gynecology (CNGOF) clinical practice guidelines based on ă the best available evidence concerning hysterectomy for benign disease. ă Methods: Each recommendation for practice was allocated a grade, which ă depends on the level of evidence (clinical practice guidelines). ă Results: Hysterectomy should be performed by a high-volume surgeon (>10 ă hysterectomy procedures per year) (grade C). Stimulant laxatives taken ă as a rectal enema are not recommended prior to hysterectomy (grade C). ă It is recommended to carry out vaginal disinfection using ă povidone-iodine solution prior to hysterectomy (grade B). Antibiotic ă prophylaxis is recommended during hysterectomy, regardless of the ă surgical approach (grade B). The vaginal or laparoscopic approach is ă recommended for hysterectomy for benign disease (grade B), even if the ă uterus is large and/or the patient is obese (grade C). The choice ă between these two surgical approaches depends on other parameters, such ă as the surgeon's experience, the mode of anesthesia, and organizational ă constraints (duration of surgery and medical economic factors). Vaginal ă hysterectomy is not contraindicated in nulliparous women (grade C) or in ă women with previous cesarean section (grade C). No specific hemostatic ă technique is recommended with a view to avoiding urinary tract injury ă (grade C). In the absence of ovarian disease and a personal or family ă history of breast/ovarian carcinoma, the ovaries should be preserved in ă premenopausal women (grade B). Subtotal hysterectomy is not recommended ă with a view to reducing the risk of peri-or postoperative complications ă (grade B). ă Conclusion: The application of these recommendations should minimize ă risks associated with hysterectomy. (C) 2016 Elsevier Ireland Ltd. All ă rights reserved.

Keywords: Quality (search for similar items in EconPapers)
Date: 2016-07
References: Add references at CitEc
Citations:

Published in European Journal of Obstetrics & Gynecology and Reproductive Biology, 2016, 202, pp.83-91. ⟨10.1016/j.ejogrb.2016.04.006⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-01482546

DOI: 10.1016/j.ejogrb.2016.04.006

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD (hal@ccsd.cnrs.fr).